Skip to main content

Table 1 Immunization schedule of the study

From: Immunization with HIV protease peptides linked to syngeneic erythrocytes

Groups

Adjuvant/Carrier1

Immunogens

Amounts

Site of injection1

Symbol used in Figure 1

PR75–84 wt

IFA

VLVGPTPVNI

4 × 50 μg

s.c

Downward pointing triangle

PR75–84 d.mut

IFA

VLVGPTPF NV

4 × 50 μg

s.c

Black filled Diamond

PR75–84 d.mut low2

-

VLVGPTPF NV

4 × 5 μg

s.c

Blue open Diamond

RBC-PR75–84 wt

RBC

VLVGPTPVNI biotinylated to synergeneic erythrocytes

2 × 5 ng3 + 2 × 12.5 ng4

i.p

Square

RBC-PR75–84 d.mut

RBC

VLVGPTPF NV biotinylated to syngeneic erythrocytes

2 × 5 ng3 + 2 × 12.5 ng4

i.p

Triangle

RBCempty

RBC

Biotinylated syngeneic erythrocytes

3 × 200 μl + 1 × 500 μl blood

i.p

Circle

Untreated

-

-

-

-

Cross

  1. 1 IFA = Incomplete Freunds adjuvant; RBC = Red blood cell; s.c = subcutaneous; i.p = intraperitoneal
  2. 2A parallel study
  3. 3 Corresponds to 200 μl blood
  4. 4 Corresponds to 500 μl blood